We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 194 results
  1. Identifying the mechanism of action of the Kv7 channel opener, retigabine in the treatment of epilepsy

    Epilepsy is characterized by recurrent epileptic seizures caused by high levels of neuronal excitability in the brain. Voltage-sensitive K+ channels...

    Aqeela Zahra, Ru Liu, ... Jian** Wu in Neurological Sciences
    Article 13 July 2023
  2. Retigabine

    Article 23 September 2023
  3. Retigabine

    Article 20 April 2019
  4. A novel loss-of-function mutation of the voltage-gated potassium channel Kv10.2 involved in epilepsy and autism

    Background

    Novel developmental mutations associated with disease are a continuous challenge in medicine. Clinical consequences caused by these...

    Jesús Galán-Vidal, Paula G. Socuéllamos, ... Alberto Gandarillas in Orphanet Journal of Rare Diseases
    Article Open access 06 September 2022
  5. The Potential of KCNQ Potassium Channel Openers as Novel Antidepressants

    Major depressive disorder (MDD) is a leading cause of disability worldwide and less than one-third of patients with MDD achieve stable remission of...

    Sara Costi, Ming-Hu Han, James W. Murrough in CNS Drugs
    Article 08 March 2022
  6. Antiepileptic-drugs

    Article 17 December 2022
  7. Activation of Kv7 channels normalizes hyperactivity of the VTA-NAcLat circuit and attenuates methamphetamine-induced conditioned place preference and sensitization in mice

    The brain circuit projecting from the ventral tegmental area (VTA) to the nucleus accumbens lateral shell (NAcLat) has a key role in methamphetamine...

    E Liu, Kunkun Pang, ... **hao Sun in Molecular Psychiatry
    Article 21 August 2023
  8. Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial

    Introduction

    XEN496 is a novel, granular, immediate-release formulation of ezogabine intended for pediatric use. The objective of this study was to...

    Rostam Namdari, Constanza Luzon, ... Gregory N. Beatch in Neurology and Therapy
    Article Open access 05 April 2022
  9. The toxic natural product tutin causes epileptic seizures in mice by activating calcineurin

    Tutin, an established toxic natural product that causes epilepsy in rodents, is often used as a tool to develop animal model of acute epileptic...

    Qing-Tong Han, Wan-Qi Yang, ... Shi-Shan Yu in Signal Transduction and Targeted Therapy
    Article Open access 10 March 2023
  10. Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy

    Impairments in cognition are common in epilepsy and may be caused or exacerbated by antiseizure medications (ASMs). Positive effects on cognition may...

    Frank M. C. Besag, Michael J. Vasey in Pediatric Drugs
    Article 06 May 2021
  11. Transient Delivery of a KCNQ2/3-Specific Channel Activator 1 Week After Noise Trauma Mitigates Noise-Induced Tinnitus

    Exposure to loud noise can cause hearing loss and tinnitus in mice and humans. In mice, one major underlying mechanism of noise-induced tinnitus is...

    Laura Marinos, Stylianos Kouvaros, ... Thanos Tzounopoulos in Journal of the Association for Research in Otolaryngology
    Article 11 February 2021
  12. Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches

    Frontotemporal lobar degeneration (FTLD) comprises a heterogenous group of fatal neurodegenerative diseases and, to date, no validated diagnostic or...

    Nadine Huber, Sonja Korhonen, ... Annakaisa Haapasalo in Molecular Psychiatry
    Article Open access 19 November 2021
  13. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond

    Epilepsy is one of the most common and disabling chronic neurological disorders. Antiseizure medications (ASMs), previously referred to as...

    Wolfgang Löscher, Pavel Klein in CNS Drugs
    Article Open access 18 June 2021
  14. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study

    Background and Objective

    Status epilepticus in poststroke epilepsy is a challenging condition because of multiple vascular comorbidities and the...

    Yaroslav Winter, Katharina Sandner, ... Sergiu Groppa in CNS Drugs
    Article Open access 02 October 2023
  15. Re-evaluating the placebo response in recent canine dietary epilepsy trials

    The placebo response is a common phenomenon. Limited evidence is available about its magnitude in canine epilepsy trials, even though it can...

    Teresa Schmidt, Nina Meyerhoff, ... Holger A. Volk in BMC Veterinary Research
    Article Open access 24 May 2024
  16. Fenfluramine in clinical practice: new therapy option for Dravet and Lennox–Gastaut syndromes

    Fenfluramine is an antiseizure medication for the treatment of Dravet and Lennox–Gastaut syndromes. This review summarizes the literature on the...

    Hiltrud Muhle, Gerhard Kurlemann, ... Milka Pringsheim in Clinical Epileptology
    Article Open access 03 January 2024
  17. Current Treatment Options for Patients with Myotonic Dystrophy Type 2

    Purpose of the review

    Myotonic dystrophy types 1 and 2 are frequent forms of muscular dystrophies in adulthood. Their clinical differences need to be...

    Article Open access 27 September 2021
  18. Blue Nail Discoloration: Literature Review and Diagnostic Algorithms

    Blue nail discoloration is a distinctive clinical presentation, and diagnosis is challenging given the broad differential diagnosis. A comprehensive...

    Jonathan K. Hwang, Shari R. Lipner in American Journal of Clinical Dermatology
    Article 27 March 2023
  19. Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations

    Due to the diverse mechanisms of action of antiseizure drugs, there has been a rise in prescriptions of these drugs for non-epileptic pathologies....

    Nathan Z. Pearl, Caroline P. Babin, ... Alan D. Kaye in Advances in Therapy
    Article 27 June 2023
  20. The efficacy and safety of ketamine in the treatment of super-refractory status epilepticus: a systematic review

    Background

    Ketamine, as an anesthetic, has been considered for terminating status epilepticus (SE); however, due to the urgency and severity of the...

    Mingyuan Yan, Tianye Sun, ... Qing Chang in Journal of Neurology
    Article Open access 23 May 2024
Did you find what you were looking for? Share feedback.